IL-18 promoter polymorphisms correlate with the development of post-injury sepsis

Surgery

Volumn 134, Issue 2, 2003, Pages 351-356

  Stassen, Nicole A ^a,b   Breit, Christina M ^a   Norfleet, Lisa A ^a   Polk Jr , Hiram C ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYTOSINE; DNA BASE; GUANINE; INTERLEUKIN 8;

ADULT; AGAR GEL ELECTROPHORESIS; ALLELE; ARTICLE; BASE PAIRING; DISEASE COURSE; DNA EXTRACTION; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INJURY; INJURY SCALE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEPSIS;

EID: 0041827043     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.248     Document Type: Article

References (24)

1. Baker CC, Oppenheimer L, Lewis FR, Trunkey DD The epidemiology of trauma death. Am J Surg 1980;140:144-50.
2. Faist E, Kupper TS, Baker CC, Chaudry IH, Dwyer J, Baue AE. Depression of cellular immunity after major injury: Its association with posttraumatic complications and its reversal with immunomodulation. Arch Surg 1986;121:1000-5.
3. Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality patterns - United States. 1900 Monthly Vital Stat Rep 1993;41:45.
4. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC. Post injury multiple organ failure: a bimodal phenomenon. J Trauma 1996;40:501-12.
5. Kwiatkowski D. Genetic dissection of the molecular pathogenesis of severe infection. Intensive Care Med 2000;26:S89-97.
6. Dinarello CA. IL-18: a TH1-inducing, pro-inflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
7. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto K, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998;8:383-90.
8. Suzuki T, Koike K, Shibata Y, Yoshida R, Ai-boshi J, Kushimoto S, et al. Serum Interleukin-18 measured in trauma patients. Surg Infect 2002;3:92.
9. Rau B, Baumgart K, Paszkowski AS, Mayer JM, Beger HG. Clinical relevance of caspase-1 activated cytokines in acute pancreatitis: high correlation of serum IL-18 with pancreatic nȩcrosis and systemic complications. Crit Care Med 2001;28:1556-62.
10. Parrello T, Monteleone G, Cucchiara S, Monteleone I, Sebkova L, Doldo P, et al. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease. J Immunol 2000;165:7234-9.
11. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human 11-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-52.
12. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Surgery and the release of a neutrophil Fc gamma receptor. Am J Surg 1995;170:277-84.
13. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1644-55.
14. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699-709.
15. Thiele DL. Hepatic dysfunction during systemic infection. In: Feldman M, Tschumy WO, Friedman LS, Sleisenger MH, editors. Sleisenger and Fordtran's gastrointestinal and liver disease. St. Louis, MO: WB Saunders; 2002. p. 1612-4.
16. Stassen NA, Leslie-Norfleet LA, Robertson AM, Eichenberger RE, Polk HC Jr. Interferon-γ gene polymorphisms and the development of sepsis in patients with trauma. Surgery 2002;132:289-92.
17. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-50.
18. Heppner G, Weiss DW. High susceptibility of strain a mice to endotoxin and endotoxin red blood cell mixtures. J Bacteriol 1965;90:696-703.
19. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-8.
20. Godshall CJ, Scott MJ, Peyton JC, Appel SA, Cheadle WG. Genetic background determines susceptibility during murine septic peritonitis. J Surg Res 2002;102:45-9.
21. Tabrizi AR, Sehnbauer BA, Freeman BD, Buchman TG. Genetic markers in sepsis. J Am Coll Surg 2001;192:106-17.
22. O'Keefe, GE, Hybki DL, Munford RS. The G 224 A single nucleotide polymorphism at the -308 position in the tumor necrosis factor-alpha promoter increases the risk for severe sepsis after trauma. J Trauma 2002;52:817-26.
23. Fang XM, Schroder S, Hoeft A, Stuber F. Comparison or two polymorphisms if the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999;27:1330-4.
24. Lowe PR, Galley HF, Abdel-Fatteh A, Webster NR. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 2003,31:348.